Timothy F. Murphy

Timothy F. Murphy is a physician scientist, research in the laboratory focuses on the respiratory tract bacterial pathogens, nontypeable Haemophilus influenzae and Moraxella catarrhalis. Both are important causes of otitis media (ear infections) in children and lower respiratory tract infections in adults with chronic obstructive pulmonary disease (COPD). Funded by the NIH, work is focusing on identifying how these bacteria cause disease in the human respiratory tract and developing vaccines and novel interventions to prevent and treat these infections. His work has resulted in ~220 publications, 13 patents, and chapters on Haemophilus and Moraxella in the major textbooks of medicine and infectious diseases.

Murphy is also Director of the UB Clinical and Translational Science Institute (CTSI), founded in 2015. The CTSI provides support and expertise to perform clinical and translational research throughout UB and partner institutions with a vision to improve health and reduce health disparities in our community and the nation. The CTSI has catalyzed a transformation of the clinical and translational research environment with a tripling of actively recruiting clinical trials since 2015 at UB.

One of the most pressing problems facing the City of Buffalo is health disparities among African Americans who live in neighborhoods on the East Side. In 2019, UB launched the UB Community Health Equity Research Institute that will conduct research that addresses the root causes of these health disparities, while developing and testing innovative solutions to the social determinants of health to eliminate health inequities in the region. He is privileged to serve as Director of the Institute, which includes faculty from ten UB schools and works closely with community partners.

Visit the Jacobs School of Medicine and Biological Sciences website for Murphy’s complete profile, including the latest research and publications.